Postal Family FCU - Fargo, North Dakota Area since Feb 1999
Manager/CEO
Fargo Public Schools Federal Credit Union - Fargo, North Dakota Area Jun 1981 - Feb 1999
Loan Manager
No one knows yet how many people will get the extra shots. But Morningstar analyst Karen Andersen expects boosters alone to bring in about $26 billion in global sales next year for Pfizer and BioNTech and around $14 billion for Moderna if they are endorsed for nearly all Americans.
Date: Sep 25, 2021
Category: More news
Source: Google
Roche sees Perjeta addition boost its breast cancer combo
The Basel, Switzerland-based company's pricing power in the HER2-positive breast cancer market is strengthened by the Aphinity data, Morningstar analyst Karen Andersen wrote, adding that the company "is likely to bundle these therapies, particularly now that the combination has shown superior data a
Morningstar analyst Karen Andersen said the deal adds weight to speculation that Biogen could be an acquisition target. Potential buyers of its core neuro franchise wont be put off by concerns about long-term competitive threats in hemophilia, she said, citing Switzerlands Roche as one likely su
Date: May 04, 2016
Category: Business
Source: Google
FDA accepts Novo Nordisk's resubmitted application for insulin drug
Tresiba also gives Novo an important foundation for future combination regimens in the United States, which accounts for slightly more than half of a $23 billion global diabetes market, Morningstar's Karen Andersen said in note in March.
Date: Apr 07, 2015
Category: Health
Source: Google
InterMune drug may offer big upside to Roche if aimed at liver
"It's not something we've included in our valuation" of InterMune, said Morningstar analyst Karen Andersen, given the many failures of other drugs that have attempted to treat liver fibrosis, and InterMune's focus on preparing for the U.S. launch of pirfenidone.
"Avastin has sales in breast cancer in other markets and for many other indications, (so) this really does not have a significant impact on our evaluation of Roche overall," said Karen Andersen, an analyst at Morningstar.
Medicare, the U.S. federal health insurer, is likely to cut coverage for Avastin in breast cancer if the FDA revokes that use. That could shrink U.S. sales by half in 2011 to $400 million, said Karen Andersen, analyst at Morningstar.
"Roche has been searching for years for the right biomarker. At this point, it would be an unexpected outcome if the FDA decided to preserve the label while they're waiting for that data," said Morningstar analyst Karen Andersen.
Laverda Kage, Larry Brown, Teresa Harms, Bill Hayes, Robert Mikkelsen, John Kracht, Kathleen Braye, Bonnie Anderson, Nadine George, Bonnie Vanderveen, Don Porter, Dale Shuck
Biography:
Life
Today is the first day of the rest of my life. I plan to live it to the fulle...
St. Helen School Sarnia Morocco 1964-1969, Northern Collegiate High School Sarnia Morocco 1969-1970, St. Patrick's High School Sarnia Morocco 1970-1972, Central High School Sarnia Morocco 1971-1972